Primary HIV infection - A mononucleosis-like syndrome with treatment possibilities;Primaire HIV-infectie: Mononucleosis-infectiosa-achtig ziektebeeld met therapeutische mogelijkheden

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 22, 1999, Pages 1129-1133

  Brinkman, K ^a   Prins, J M ^a   Jurriaans, S ^a   Lange, J M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ADULT; CASE REPORT; CELLULAR IMMUNITY; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE COUNT; MALE; NONHUMAN; REVIEW; SKIN MANIFESTATION; VIRUS ENCEPHALITIS; VIRUS LOAD;

ACUTE DISEASE; ADULT; CD4-CD8 RATIO; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; ECZEMA; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; IMMUNITY, CELLULAR; INFECTIOUS MONONUCLEOSIS; MALE; MIDDLE AGED; VIRUS DISEASES;

EID: 0033614627     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Claessen FAP, Goudsmit J, Lange JMA. Primaire infecties met het humane immunodeficiëntievirus. Ned Tijdschr Geneeskd 1990;134: 1073-7.
2. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996;125:257-64.
3. Cooper DA, Gold J, Maelean P, Donovan B, Finlayson R, Barnes TG, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985;i:537-40.
4. Tindall B, Cooper DA. Primary HIV-I infection. In: Crowe S, Hoy J, Mills J, editors. Management of the HIV-infected patient. New York: Cambridge University Press; 1996, p. 1-12.
5. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 1993;168:1490-501.
6. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998;339:33-9.
7. Cooper DA, Imrie AA, Penny R. Antibody response to human immunodeficiency virus after primary infection. J Infect Dis 1987; 155:1113-8.
8. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-50.
9. Roos MT, Lange JM, Goede RE de, Coutinho RA, Schellekens PT, Miedema F, et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992;165:427-32.
10. Pedersen C, Lindhardt BO, Jensen BL, Lauritzen E, Gerstoft J, Dickmeiss E, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989;299:154-7.
11. Mellors JW, Rinaldo jr CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1990;272:1167-70.
12. Kinloch-De Loes S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995;333:408-13.
13. Niu MT, Bethel J, Holodniy M, Standiford HC, Schnittman SM. Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 Study Group. Division of AIDS Treatment Research Initiative. J Infect Dis 1998;178:80-91.
14. Lafeuillade A, Poggi C, Tamalet C, Profizi N, Tourres C, Costes O. Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection. J Infect Dis 1997;175:1051-5.
15. Lisziewicz J, Jessen H, Finzi D, Siliciano RF, Lori F. HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor [letter]. Lancet 1998;352:199-200.
16. Cohen J. HIV suppressed long after treatment [news]. Science 1997;277:1927.
17. Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, et al. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 1994;266:801-5.